Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia
Anecdotal evidence suggests milrinone improves oxygenation in pulmonary hypertension associated with congenital diaphragmatic hernia.
Patients diagnosed with an intermediate-risk pulmonary embolism may be able to start oral anticoagulation therapy after completing 72 hours of heparin therapy during hospitalization.
Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.
Treprostinil, a prostacyclin derivative, used in an implantable delivery system may be an effective treatment alternative for pulmonary arterial hypertension.